Reproduction   citetrack
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  

Journal of Reproduction and Fertility (1969) 19 185-NP
DOI: 10.1530/jrf.0.0190185
Copyright © 1969 Society for Reproduction and Fertility
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by APPELGREN, L.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by APPELGREN, L.-E.

HISTOCHEMICAL DEMONSTRATION OF DRUG INTERFERENCE WITH PROGESTERONE SYNTHESIS

LARS-ERIK APPELGREN

Autoradiography of some labelled steroid hormone precursors in mice has shown that these substances are localized to a great extent in sites of steroid hormone formation (Appelgren, 1967). Pregnenolone—the immediate precursor of progesterone—was specifically accumulated in the corpora lutea (Pl. 1, Fig. 1).

Some synthetic substances of diphenyl alkene character, F6060, bis-(p-hydroxyphenyl)cyclohexylidenemethane, (Ferrosan Ltd, Sweden), and its derivatives, F6066, F6103, have also been shown to concentrate in corpora lutea (Hanngren, Einer-Jensen & Ullberg, 1965a; Appelgren, Einer-Jensen & Ullberg, unpublished observations). It was postulated that these substances might interfere with the corpus luteum function, and perhaps with progesterone synthesis. When tested pharmacologically they were found to have antigestagenic properties (Hanngren, Einer-Jensen & Ullbert, 1965b; Einer-Jensen, 1968). It was later shown in vitro that F6066 reduced the synthesis of progesterone from pregnenolone by interference







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Copyright © 1969 by the Society for Reproduction and Fertility.